The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s prenatal DNA sequencing market report forecasts the prenatal DNA sequencing market size to grow to $3.52 Billion by 2027, with a CAGR (compound annual growth rate) of almost 14%.

Learn More On The Prenatal DNA Sequencing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Prenatal DNA Sequencing Market Size Forecast
The global prenatal DNA sequencing market is expected to grow from $1.84 billion in 2022 to $2.09 billion in 2023 at a compound annual growth rate (CAGR) of 13.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The prenatal DNA sequencing market is expected to grow to $3.52 billion in 2027 at a CAGR of 13.9%.

North America held the largest prenatal DNA sequencing market share.

Key Prenatal DNA Sequencing Market Driver ­– Increase In The Prevalence Of Cancer
According to Globocan, a Swiss-based provider of a global database of cancer incidence and mortality rates, there will be approximately 19.29 million new cancer cases in 2020, with the total number of cancer cases over a 5-year period estimated to be 50.55 million. As a result, the prenatal DNA sequencing market is being driven by the prevalence of cancer.

Request for A Sample Of The Global Prenatal DNA Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9015&type=smp

Key Prenatal DNA Sequencing Market Trend – Product Innovation
Major market players are focusing on developing innovative solutions to strengthen their market position. For example, Juno Diagnostics, Inc., a US-based health technology company that democratises access to valuable genetic information, will launch the noninvasive prenatal screening test “Hazel” in November 2022. The test is unique in that there is no risk of miscarriage and that it can be performed as early as 9 weeks into pregnancy using a small amount of blood. It checks for common genetic conditions caused by extra or missing chromosomes, such as Down syndrome, Edwards syndrome, and Patau syndrome, during the pregnancy.

Prenatal DNA Sequencing Market Segment
1) By Type: Genetic Diseases, Nonhereditary Diseases
2) By Application: Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorgre Syndrome, AIDS (Acquired Immunodeficiency Syndrome), Cancer, Other Applications
3) By End User: Academic Research, Clinical Research, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Prenatal DNA Sequencing Market Major Players and Strategies
Major players in the prenatal DNA sequencing market are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences, Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, and Thermo Fisher Scientific Inc.

Myriad Genetics, Inc., a US-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC for an undisclosed sum in November 2022. With the combined resources of this acquisition, Myriad expects to expand and strengthen its portfolio of women’s health products, as well as provide access to personalised genetic tests. Gateway Genomics, LLC is a personal genomics and prenatal DNA company based in the United States that also develops consumer genetic tests.

The Prenatal DNA Sequencing Global Market Report 2023 covers regional data on prenatal DNA sequencing market size, prenatal DNA sequencing market trends and drivers, opportunities, strategies, and prenatal DNA sequencing market competitor analysis. The countries covered in the prenatal DNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Prenatal DNA sequencing is a method of sequencing the DNA of an unborn baby using a blood sample from the mother, which helps to reveal the full genetic code of the unborn baby. It is used to detect foetal disorders or diseases.

View More Reports Related To The Prenatal DNA Sequencing Market –
Prenatal Testing And Newborn Screening Global Market Report 2023
DNA Based Skin Care Products Global Market Report 2023
DNA And Gene Chip Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: